235 SAPPHIRE II: Phase 3 Placebo-Controlled Study of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333, and Ribavirin in 394 Treatment-Experienced Adults With Hepatitis C Virus Genotype 1
Year: 2014
Type: article
Source: Gastroenterology
Authors: Ira M. Jacobson, Stefan Zeuzem, Tolga Baykal, Rui T. Marinho, Fred Poordad, Marc Bourliere, Mark Sulkowski, Heiner Wedemeyer, Edward Tam, Paul V. Desmond, Donald M. Jensen, Adrian M. Di Bisceglie, Peter Varunok, Tarek Hassanein, Junyuan Xiong, Barbara DaSilva-Tillmann, Lois Larsen, Thomas Podsadecki
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4252376837